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Background
Left-ventricular (LV) shape remodeling has known asso-
ciation with cardiac pathophysiology and dysfunction.
While a prolate spheroid shape is vital for optimal car-
diac function, LV dilatation and high sphericity is char-
acteristic of cardiomyopathy. Early quantification of
abnormal LV morphology may potentially guide clinical
decisions to check disease progression. However a quan-
titative biomarker of 3D LV morphometry is found
wanting in routine clinical practice as an upgrade to the
rudimentary sphericity index.
Methods
Spherical harmonics (SPHARM) shape descriptors were
sought to quantify patient-specific LV shape. Morpho-
metric variation from a normal LV shape was studied with
application to diagnostic identification of cardiomyopathy.
Cardiac MR (CMR) was employed for anatomical exami-
nation and end-diastolic LV endocardial surface models
were segmented from short-axis SSFP cine scans of 11
pediatric subjects between the ages 2 and 17. Surface mod-
els were individually registered by rigid transformation and
scaling to match the LV base diameter of a reference 17
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Diagnosis Sphericity Age MDP % of normal
LV length








1 ARVD 0.600 2 14.408 4.307 2 5 8
2 ARVD 0.625 6 14.826 4.083 5 6 7
3 ARVD 0.643 7 22.460 5.648 6 12 12
4 LVH 0.672 8 17.546 4.789 8 10 9
5 ARVD 0.703 9 11.82 5.464 10 2 11
6 ARVD 0.726 11 11.941 3.731 11 3 6
7 NORMAL 0.616 13 13.860 3.496 3 4 5
8 ARVD 0.703 15 15.282 2.879 9 8 2
9 LVH 0.625 16 15.930 2.953 4 9 3
10 MI 0.726 16 18.913 5.099 12 11 10
11 NORMAL
*
0.584 17 0.000 0.000 1 1 1
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year old normal LV that approximated well to a prolate
spheroid. Two characteristic morphometric difference per-
centages (DP) were computed as a percentage of normal
LV length for each case with respect to the reference nor-
mal model i.e. maximum DP (MDP) and average DP
(ADP). A 16 patient cohort was used for training, compris-
ing 10 simulated normals (ADP < 3.5 % & MDP < 13%)
and 6 abnormal cases including 2 with LV hypertrophy
(LVH), 3 with arrythmogenic right ventricular dysplasia
(ADVD), 1 post myocardial infarction (MI). Rule-based
decision trees were prepared to predict a response func-
tion defining normal vs. pathological cases using the new
MDP and ADP predictors simultaneously with the con-
ventional LV sphericity index as a third predictor, through
a 3D generative clustering approach. Classification accu-
racy was evaluated with a 6 patient test cohort comprising
3 ARVDs, 2 LVH and 2 normal subjects.
Results
The underlying principle of this LV-base normalized dif-
feomorphic analysis is that LV remodeling is accompa-
nied by heightened sphericity. This assumption was
verified by the existence of positive Spearman rank cor-
relations for sphericity with ADP (0.41) and MDP
Figure 1 Top left: Generative classification result in a 3D space defined by sphericity, MDP and ADP (Red: pathology, Blue: normal). Each patient
is identified by a label constituted of “Age, Diagnosis” . Top right: Decision tree produced from the training data set, using either MDP or ADP.
Bottom: 3D morphometric difference colormap mapped onto the surface of a pathological LV model. 40th degree SPHARM representations of a
normal and a representative pathological LV endocardium surfaces are shown, as well.
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(0.28). 100% test classification accuracy was obtained
using a simultaneous thresholds for MDP (>13.9%),
ADP (>3.5%) and sphericity (>0.7). ARVD patients were
all identified as pathologies based upon LV shape alone.
Further, strong correlation (0.94) was observed between
LV sphericity and age for ARVD patients.
Conclusions
This pilot study suggests DP is a valuable biomarker in
identifying cardiomyopathy. Strong correlation between
sphericity and ARVD patient age combined with the excel-
lent classification of ARVD as a cardiomyopathy by LV
shape alone supports possible left-sided involvement in
ARVD. Analysis with a larger cohort comprising more
normal controls is warranted to validate this hypothesis.
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